Cleared Traditional

K142850 - McKesson Radiology Mammography Plus

K142850 is an FDA 510(k) clearance for McKesson Radiology Mammography Plus, manufactured by Mckesson Medical Imaging Company. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 98-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jan 2015
Decision
98d
Days
Class 2
Risk

K142850 is an FDA 510(k) clearance for the McKesson Radiology Mammography Plus. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Mckesson Medical Imaging Company (Richmond, B.C., CA). The FDA issued a Cleared decision on January 6, 2015 after a review of 98 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

FDA 510(k) Submission Details - K142850

510(k) Number K142850 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 30, 2014
Decision Date January 06, 2015
Days to Decision 98 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
9d faster than avg
Panel avg: 107d · This submission: 98d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Mckesson Technologies, Inc.
PAUL SUMNER

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2230
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K142850.
VM PACS WITH VM MEDICAL WORKSTATION
K141561 · Visual Medica · Jan 2015
MR-CT VVA
K140587 · Medis Medical Imaging Systems BV · Jan 2015
IMPAX Agility
K142316 · Agfa Healthcare N.V. · Jan 2015
UniWeb 8.0
K142514 · Ebm Technologies Incorporated · Dec 2014
HEPATIQ
K142891 · Hepatiq, LLC · Dec 2014
ImmersiveTouch3 and MicrovisTouch
K140860 · Immersivetouch · Dec 2014